July 12, 2018

FDA statement on access to opioids for patients with chronic, end-of-life pain

By: Judy Mathias
Share

Editor’s Note

Food & Drug Administration (FDA) commissioner, Scott Gottlieb, MD, on July 9 issued a statement on balancing access to appropriate treatment for patients with chronic and end-of-life pain with the need to stem the misuse and abuse of opioids.

As the FDA considers new steps to address the opioid addiction crisis, Gottlieb says, the agency remains focused on striking the right balance between reducing the rate of new addictions by rationalizing prescribing, while still enabling appropriate access to those who have legitimate needs for opioids.

Read More >>
Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

Live chat by BoldChat